MMS Holdings announced that the company has successfully assisted Korea-based Vivozon in achieving a Fast Track Designation from the Food and Drug Administration (FDA) for VVZ-149, a non-opioid pain killer.
MMS Holdings announced that the company has successfully assisted Korea-based Vivozon in achieving a Fast Track Designation from the Food and Drug Administration (FDA) for VVZ-149, a non-opioid pain killer.